FTO has already been confirmed to be a protective m6A regulator in myocardial fibrosis (Mathiyalagan, Adamiak et al. 2019, Ju, Liu et al., 2021), while the function of LRPPRC on fibrotic diseases is still unknown. The gene discussed is LRPPRC; the disease is Myocardial fibrosis.